I originally found that article on Abbotts home page. You are correct in that it was in 2004. Looks like Abbott has been wanting a good cancer marker for some time.
That company looks as if it ran out of money. My guess is whatever they were selling wasn't panning out.
My reason for posting it was I wanted to see how much the payments were from Abbott + wanted to show the interest from abbott in 2003/ 2004 for biomarker work.
I believe that Abbott does know that they have a great product I.E. Recaf. We will know shortly. Also we don't actually know what the lisencing agreement allows Abbott to use...
Is this only for prostate or ??????. I don't believe we were privileged to that info.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.